Munchen, Germany

Axel Koch

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Axel Koch - Innovator in Transdermal Therapeutics

Introduction

Axel Koch is a notable inventor based in Munich, Germany. He has made significant contributions to the field of transdermal therapeutics, particularly with his innovative approach to drug delivery systems. His work focuses on enhancing the efficacy and safety of medication administration through the skin.

Latest Patents

One of Axel Koch's key patents is a transdermal therapeutical system comprising physostigmine as the active ingredient. This invention relates to a system designed for the administration of physostigmine to the skin via a cover layer that is impermeable to active substances. The system includes a pressure-sensitive adhesive reservoir layer and, optionally, a removable protective layer. The reservoir layer consists of 10-90% polymeric material selected from various groups, including block copolymers based on styrene and 1,3-dienes, polyisobutylenes, and polymers based on acrylates and/or methacrylates. Additionally, it may contain softeners and 0.1-20% physostigmine.

Career Highlights

Throughout his career, Axel Koch has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with LTS Lohmann Therapie-Systeme GmbH & Co. KG and Klinge Pharma GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug delivery systems.

Collaborations

Axel Koch has collaborated with esteemed colleagues, including Thomas Hille and Hans-Rainer Hoffmann. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Axel Koch's contributions to transdermal therapeutics exemplify the impact of innovation in the pharmaceutical field. His work continues to influence the way medications are delivered, enhancing patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…